These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6189570)
21. Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis. Kadival GV; Chaparas SD; Hussong D J Immunol; 1987 Oct; 139(7):2447-51. PubMed ID: 2443566 [TBL] [Abstract][Full Text] [Related]
22. Ribosomes as carriers for antigenic determinants of the surface of micro-organisms. Normier G; Pinel AM; Dussourd d'Hinterland L; Wigzell H; Binz H Dev Biol Stand; 1992; 77():79-85. PubMed ID: 1385236 [TBL] [Abstract][Full Text] [Related]
23. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis. Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075 [TBL] [Abstract][Full Text] [Related]
24. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. Al-Attiyah R; Mustafa AS; Abal AT; Madi NM; Andersen P FEMS Immunol Med Microbiol; 2003 Oct; 38(3):249-56. PubMed ID: 14522460 [TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein. Deng YH; He HY; Zhang FJ Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772 [TBL] [Abstract][Full Text] [Related]
26. Differential Immune Responses and Protective Effects in Avirulent Mycobacterial Strains Vaccinated BALB/c Mice. Liu L; Fu R; Yuan X; Shi C; Wang S; Lu X; Ma Z; Zhang X; Qin W; Fan X Curr Microbiol; 2015 Jul; 71(1):129-35. PubMed ID: 25995039 [TBL] [Abstract][Full Text] [Related]
27. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy. Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843 [TBL] [Abstract][Full Text] [Related]
28. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis. Johnson W Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407 [TBL] [Abstract][Full Text] [Related]
29. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Feng CG; Palendira U; Demangel C; Spratt JM; Malin AS; Britton WJ Infect Immun; 2001 Jun; 69(6):4174-6. PubMed ID: 11349095 [TBL] [Abstract][Full Text] [Related]
30. Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium. Misfeldt ML; Johnson W Infect Immun; 1979 Jun; 24(3):808-16. PubMed ID: 381202 [TBL] [Abstract][Full Text] [Related]
31. Separate antigenic determinants on cell wall associated carbohydrate antigens of Mycobacterium leprae defined with monoclonal antibodies. Britton WJ; Hellqvist L; Basten A Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):545-55. PubMed ID: 2434585 [TBL] [Abstract][Full Text] [Related]
32. Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis. Thomas DW; Weiss E Infect Immun; 1972 Sep; 6(3):355-63. PubMed ID: 4629260 [TBL] [Abstract][Full Text] [Related]
33. Chemical composition of antigen 60 from Mycobacterium bovis BCG. Fabre I; L'Homme O; Bruneteau M; Michel G; Cocito C Scand J Immunol; 1986 Nov; 24(5):591-602. PubMed ID: 3538372 [TBL] [Abstract][Full Text] [Related]
34. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium. Venneman MR; Bigley NJ J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982 [TBL] [Abstract][Full Text] [Related]
35. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG. Haga S; Yamaguchi R; Nagai S; Matsuo K; Yamazaki A; Nakamura RM J Leukoc Biol; 1995 Feb; 57(2):221-5. PubMed ID: 7531745 [TBL] [Abstract][Full Text] [Related]
36. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Brennan PJ Rev Infect Dis; 1989; 11 Suppl 2():S420-30. PubMed ID: 2469120 [TBL] [Abstract][Full Text] [Related]
37. Biochemistry of BCG lipids and their role in antituberculous immunity and hypersensitivity. Mára M; Galliová J; Sir Z; Mohelská H; Prüchová J; Julák J J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):444-52. PubMed ID: 1107417 [No Abstract] [Full Text] [Related]
38. Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions. Coppel S; Youmans GP J Bacteriol; 1969 Jan; 97(1):114-20. PubMed ID: 4974383 [TBL] [Abstract][Full Text] [Related]
39. [Attempts at isolation and characterization of immunogenically active fractions of Mycobacterium tuberculosis and Mycobacterium bovis (BCG). 3. Immunochemical properties of the fractions]. Klose F; Schallehn G Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):201-18. PubMed ID: 4231179 [No Abstract] [Full Text] [Related]
40. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). II. Physical-chemical characterization of the fractions]. Klose F; Schallehn G Z Immunitatsforsch Allerg Klin Immunol; 1966 Aug; 131(2):121-33. PubMed ID: 4231174 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]